// App-Quantinova.ai

4438 : A bispecific antibody targeting CD28H and PDL-1 is a novel and potent immunomodulator of T cell responses

Researchers

Presenter

  • Madhu Ramaswamy

Principal Investigators

  • Taeil Kim

  • Desmond Jones

  • Hormas Ghadially

  • Tamer Mahmoud

  • Andrew Garcia

  • Susan Wilson

  • Jeffrey Riggs

  • Darren Schofield

  • GIanluca Carlesso

Medical Centers

  • AstraZeneca, Gaithersburg, MD

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 2AP

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Cytotoxic T-lymphocyte-associated protein 4

  • tumor-infiltrating lymphocytes

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved